Placebo effects in developmental disabilities: Implications for research and practice

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 11, Issue 2, 2005, Pages 164-170

  Sandler, Adrian ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Mission Children's Hospital   (United States)

^c Olson Huff Center   (United States)

Author keywords

ADHD; Autism; Conditioning; Disabilities; Placebo; Research

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; PLACEBO; PSYCHOSTIMULANT AGENT; RISPERIDONE; SECRETIN; SEROTONIN UPTAKE INHIBITOR;

ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; AUTISM; CAREGIVER; CHILD BEHAVIOR; CHILD CARE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DISABILITY; DOCTOR PATIENT RELATION; ELECTROENCEPHALOGRAM; FEEDBACK SYSTEM; HUMAN; HYPERACTIVITY; HYPERBARISM; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOCIAL BEHAVIOR; TREATMENT OUTCOME;

CHILD; HUMANS; MENTAL RETARDATION; PHYSICIAN'S PRACTICE PATTERNS; PLACEBO EFFECT; RESEARCH;

EID: 22144432234     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.20065     Document Type: Review

References (35)

1. Ader R, Cohen N, Bovbjerg D. 1982. Conditioned suppression of humoral immunity in the rat. J Comp Physiol Psychol 96:517-521.
2. Beck G, Beck V. 1998. Unlocking the potential of secretin: information and questions for parents and physicians who want to learn more about secretin as its use is explored in autism and other disorders. San Diego, CA: Autism Research Institute.
3. Bell IR, Lewis DA, Brooks AJ, et al. 2004. Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: Implications of a double-blinded optional crossover design. J Altern Complement Med 10:269-283.
4. British Medical Journal. 1952. The bottle of medicine. Br Med J 1:149-150.
5. Brown WA. 1994. Placebo as a treatment for depression. Neuropsychopharmacology 10:287-288.
6. Challis GB, Stam HJ. 1992. A longitudinal study of the development of anticipatory nausea and vomiting in cancer chemotherapy patients: The role of absorption and autonomic perception. Health Psychol 11:181-189.
7. Collet JP, Vanasse M, Marois P, et al. 2001. Hyperbaric oxygen for children with CP: A randomised multicentre trial. HBO-CP Research Group. Lancet 357:582-586.
8. de Craen AJ, Tijssen JG, de Gans J, et al. 2000. Placebo effect in the acute treatment of migraine: Subcutaneous placebos are better than oral placebos. J Neurol 247:183-188.
9. Derivan AT, Leventhal BL, March J, et al. 2004. The ethical use of placebo in clinical trials involving children. J Child Adolesc Psychopharmacol 14:169-174.
10. Frank JD. 1973. Persuasion and Healing. Baltimore, MD: Johns Hopkins University Press.
11. Harrington A (editor). 1997. The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press: p 7.
12. Horwitz RI, Horwitz SM. 1993. Adherence to treatment and health outcomes. Arch Intern Med 153:1863-1868.
13. Hrobjartsson A, Gotzsche PC. 2001. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344:1594-1602.
14. Kirsch I. 1994. Clinical hypnosis as a nondeceptive placebo: Empirically derived techniques. Am J Clin Hypn 37:95-106.
15. Leuchter AF, Morgan M, Cook IA, et al. 2004. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) 177:15-22.
16. Levine JD, Gordon NC, Fields HL. 1978. The mechanism of placebo analgesia. Lancet 2:654-657.
17. March J, Kratochvil C, Clarke G, et al. 2004. AACAP 2002 research forum: Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 43:1046-1056.
18. Mayberg HS, Silva JA, Brannan SK, et al. 2002. The functional neuroanatomy of the placebo effect. Am J Psychiatry 159:728-737.
19. McCracken JT, McGough J, Shah B. 2002. Risperidone in children with autism and serious behavior problems. N Engl J Med 347:314-321.
20. Monastra VJ. 2005. Electroencephalographic biofeedback as a treatment for attention deficit hyperactivity disorder. Child Adolesc Psychiatry Clin N Am 14:55-82. vi.
21. Nitzan U, Lichtenberg P. 2004. Questionnaire survey on use of placebo. Br Med J 329:944-946.
22. Olness K, Ader R. 1992. Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus. J Dev Behav Pediatr 13:124-125.
23. Park LC, Covi L. 1965. Nonblind placebo trial: An exploration of neurotic patients' responses to placebo when its inret content is disclosed. Arch Gen Psychiatry 12:336-345.
24. Rausch JL, Johnson ME, Fei YJ, et al. 2002. Initial conditions of serotonin transporter kinetics and genotype: Influence on SSRI treatment trial outcome. Biol Psychiatry 51:723-732.
25. Sandler AD, Bodfish JW. 2000. The placebo effect in autism. J Dev Behav Pediatr 21:347-350.
26. Sandler AD, Sutton KA, DeWeese J, et al. 1999. Lack of benefit of synthetic human secretin in the treatment of autism and pervasive developmental disabilities. N Engl J Med 341:1801-1806.
27. Sandler AD, Bodfish JW. 2003. Therapeutic use of placebos in the treatment of ADHD: A pilot study. Presented at the Pediatric Academic Societies Meeting, Seattle, WA, May 2003.
28. Shapiro AK, Shapiro E. 1997. The placebo: Is it much ado about nothing? In: Harringon A, editor. The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press. pp 13-14.
29. Spiegel D, Bloom JR, Kraemer HC et al. 1989. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891.
30. Spiro H. 1997. Clinical reflections on the placebo phenomenon. In: Harrington A, editor. The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press. pp 37-55.
31. Sugarman J. 2004. Using empirical data to inform the ethical evaluation of placebo controlled trials. Sci Eng Ethics 10:29-35.
32. Swanson JM, McBurnett K, Christian DL, et al. 1995. Stimulant medications and the treatment of children with ADHD. In: Ollendick TH, Prinz RJ, editors. Advances in Clincal Child Psychology. New York: Plenum Press. pp 265-322.
33. Wall Street Journal, June 18 2004.
34. Walsh BT, Seidman SN, Sysko R, et al. 2002. Placebo response in studies of major depression: Variable, substantial, and growing. J Am Med Assoc 287:1840-1847.
35. Wickramasekera I. 1980. A conditioned response model of the placebo. Biofeedback Self-Regul 5:5-18.